Introduction: Dual kidney transplantation is one of the options to utilize the so-called marginal grafts, kidneys that would be insufficient for normal single transplantation. This time-consuming surgical procedure is also burdensome for the patient.
Methods: The authors present their experience from the Pilsen Transplant Center. Between 2008 and 2016, 13 dual kidney transplantations were performed. Median donor age was 66 years (34-77) and median recipient age 46 years (40-78). Mean operating time was 4 hours and 40 minutes (3-6 h). Mean surgery ward stay was 5 days (4-6). Bilateral surgical technique was used in all cases. Mean follow-up time was 63 months (18-101).
Results: From our group of DKTs (N=13), 4 patients (31%) experienced delayed graft function and we observed no primary graft non-function. Surgical complications occurred in 4 patients (31%). Currently, all 13 patients are living with good graft function, none of them being dependent on dialysis.
Conclusion: Dual kidney transplantation is currently a viable option. The success and benefits of this surgical procedure are directly related to careful donor and recipient selection.Key words: dual kidney transplantation - marginal donor - chronic renal failure - expanded criteria donor.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
De novo proliferative glomerulonephritis with monoclonal IgG deposits in an adolescent kidney transplant recipient.
Pediatr Nephrol
January 2025
Department of Pediatrics, University of California, San Diego, 3020 Children's Way MC 5173, San Diego, CA, 92123, USA.
Proliferative Glomerulonephritis with Monoclonal IgG Deposits (PGNMID) is a glomerular disease characterized by membranoproliferative and mesangioproliferative lesions, with granular capillary wall monoclonal IgG positivity and immunoglobulin light chain restriction. Most commonly a disease of older adults, we present the case of an 18-year-old patient who developed de novo PGNMID in a kidney allograft three years after kidney transplantation. There was minimal proteinuria and no serum paraproteinemia was detected, so the patient was managed conservatively.
View Article and Find Full Text PDFEfficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy.
Pediatr Nephrol
January 2025
Center for HUS Prevention, Control and Management at the Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Background: C3 glomerulopathy (C3G) is a rare kidney disease due to a dysregulation of the alternative complement pathway, orphan of specific treatment. Pegcetacoplan is an inhibitor of the third complement component C3, currently on a phase III registration protocol in C3G. Here we describe our experience with the off-label use of pegcetacoplan in pediatric patients with C3G.
View Article and Find Full Text PDFCell cycle arrest biomarkers for early diagnosis of acute kidney injury after liver transplantation: A prospective cohort study.
Eur J Anaesthesiol
January 2025
From the Department of Anaesthesia, King's College Hospital NHS Foundation Trust, London, UK (BM, GK), Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK (KM, MM), Department of Critical Care, Guy's & St Thomas' NHS Foundation Trust, London, UK (MO), Department of Critical Care, University of Pittsburgh, USA (JAK), School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, UK (GK).
Introduction: Living-donor kidney transplantation (LDKT) is often performed using hand-assisted laparoscopic donor nephrectomy (HALDN). Adherent perinephric fat (APF) can complicate HALDN, increasing operative time. The Mayo Adhesive Probability (MAP) score predicts APF preoperatively.
View Article and Find Full Text PDFEvaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomes.
Front Immunol
January 2025
Department of Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
In the face of growing transplant waitlists and aging donors, sound pre-transplant evaluation of organ offers is paramount. However, many transplant centres lack clear criteria on organ acceptance. Often, previous scores for donor characterisation have not been validated for the Eurotransplant population and are not established to support graft acceptance decisions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!